Stock Research: Eisai

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Eisai

TSE:4523 JP3160400002
23
  • Value
    47
  • Growth
    28
  • Safety
    Safety
    54
  • Combined
    32
  • Sentiment
    32
  • 360° View
    360° View
    23
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Eisai Co Ltd is a Japanese pharmaceutical company focused on the research, development, manufacture, and sale of pharmaceuticals. It operates in the pharmaceutical industry, with brands like Lembima and Halaven. Key regions include Japan, the Americas, China, EMEA, Asia, and Latin America. In the last fiscal year, the company had a market cap of $7,686 million, profits of $4,139 million, revenue of $5,264 million, and 13506 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 23 (better than 23% compared with alternatives), overall professional sentiment and financial characteristics for the stock Eisai are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Eisai. Only the consolidated Value Rank has an attractive rank of 54, which means that the share price of Eisai is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 54% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 28, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 47, meaning the company has a riskier financing structure than 53% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 68% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 32. ...read more

more
Index
TOPIX 100
Nikkei 225
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 64 32 41
Growth
28 16 31 21
Safety
Safety
47 47 47 53
Sentiment
32 22 4 16
360° View
360° View
23 24 8 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
31 24 37 26
Opinions Change
86 54 15 50
Pro Holdings
n/a 66 14 59
Market Pulse
27 11 16 17
Sentiment
32 22 4 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 64 32 41
Growth
28 16 31 21
Safety Safety
47 47 47 53
Combined
32 33 18 28
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
35 40 24 29
Price vs. Earnings (P/E)
53 67 38 46
Price vs. Book (P/B)
51 50 40 50
Dividend Yield
81 86 62 55
Value
54 64 32 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
38 43 54 18
Profit Growth
49 39 19 72
Capital Growth
28 26 67 30
Stock Returns
42 18 23 33
Growth
28 16 31 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
39 46 55 58
Refinancing
52 46 45 41
Liquidity
49 46 51 57
Safety Safety
47 47 47 53

Similar Stocks

Discover high‑ranked alternatives to Eisai and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Daiwabo Holdings

TSE:3107
Country: Japan
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Hisamitsu Pharmaceutical

TSE:4530
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.